Effect of preventive heart failure treatment in mice with arrhythmogenic right ventricular cardiomyopathy type 5 due to mutation in TMEM43

22 April 2018 (15:20 - 15:30)
Organised by: Logo
Congress Presentation Part of: Molecular basis for arrhythmias and beyond Cardiomyopathies Open Access Frontiers in CardioVascular Biology 2018 Council on Basic Cardiovascular Science

ESC 365 is supported by

ESC 365 is supported by